001     289207
005     20240425122529.0
024 7 _ |a 10.1084/jem.20231044
|2 doi
024 7 _ |a pmid:38557723
|2 pmid
024 7 _ |a 0022-1007
|2 ISSN
024 7 _ |a 1540-9358
|2 ISSN
024 7 _ |a 1540-9538
|2 ISSN
024 7 _ |a altmetric:161442172
|2 altmetric
037 _ _ |a DKFZ-2024-00641
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Guérin, Antoine
|0 0000-0001-6810-1607
|b 0
245 _ _ |a Helper T cell immunity in humans with inherited CD4 deficiency.
260 _ _ |a New York, NY
|c 2024
|b Rockefeller Univ. Press
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1712309296_11099
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a CD4+ T cells are vital for host defense and immune regulation. However, the fundamental role of CD4 itself remains enigmatic. We report seven patients aged 5-61 years from five families of four ancestries with autosomal recessive CD4 deficiency and a range of infections, including recalcitrant warts and Whipple's disease. All patients are homozygous for rare deleterious CD4 variants impacting expression of the canonical CD4 isoform. A shorter expressed isoform that interacts with LCK, but not HLA class II, is affected by only one variant. All patients lack CD4+ T cells and have increased numbers of TCRαβ+CD4-CD8- T cells, which phenotypically and transcriptionally resemble conventional Th cells. Finally, patient CD4-CD8- αβ T cells exhibit intact responses to HLA class II-restricted antigens and promote B cell differentiation in vitro. Thus, compensatory development of Th cells enables patients with inherited CD4 deficiency to acquire effective cellular and humoral immunity against an unexpectedly large range of pathogens. Nevertheless, CD4 is indispensable for protective immunity against at least human papillomaviruses and Trophyrema whipplei.
536 _ _ |a 314 - Immunologie und Krebs (POF4-314)
|0 G:(DE-HGF)POF4-314
|c POF4-314
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
700 1 _ |a Moncada-Vélez, Marcela
|0 0000-0002-3073-5345
|b 1
700 1 _ |a Jackson, Katherine
|0 0000-0002-9952-7069
|b 2
700 1 _ |a Ogishi, Masato
|0 0000-0003-2421-7389
|b 3
700 1 _ |a Rosain, Jérémie
|0 0000-0002-2822-161X
|b 4
700 1 _ |a Mancini, Mathieu
|0 0000-0002-4981-7121
|b 5
700 1 _ |a Langlais, David
|0 0000-0003-4429-0110
|b 6
700 1 _ |a Nunez, Andrea
|0 0000-0002-0182-1834
|b 7
700 1 _ |a Webster, Samantha
|0 0000-0003-2494-5191
|b 8
700 1 _ |a Goyette, Jesse
|0 0000-0002-1008-1890
|b 9
700 1 _ |a Khan, Taushif
|0 0000-0002-7917-8965
|b 10
700 1 _ |a Marr, Nico
|0 0000-0002-1927-7072
|b 11
700 1 _ |a Avery, Danielle T
|0 0000-0002-9156-0489
|b 12
700 1 _ |a Rao, Geetha
|0 0009-0007-2744-9309
|b 13
700 1 _ |a Waterboer, Tim
|0 P:(DE-He78)6b4ebb9791b983b5620c0caaf3468e30
|b 14
|u dkfz
700 1 _ |a Michels, Birgitta
|0 P:(DE-He78)b48bfd64120195b64b5f11d32ce5ed5e
|b 15
|u dkfz
700 1 _ |a Neves, Esmeralda
|0 0000-0002-7754-8109
|b 16
700 1 _ |a Iracema Morais, Cátia
|0 0000-0003-2814-9248
|b 17
700 1 _ |a London, Jonathan
|0 0000-0002-8857-111X
|b 18
700 1 _ |a Mestrallet, Stéphanie
|0 0009-0007-6427-6128
|b 19
700 1 _ |a Quartier Dit Maire, Pierre
|0 0000-0002-1769-549X
|b 20
700 1 _ |a Neven, Bénédicte
|0 0000-0001-8941-0935
|b 21
700 1 _ |a Rapaport, Franck
|0 0000-0001-6553-2110
|b 22
700 1 _ |a Seeleuthner, Yoann
|0 0009-0000-2670-6026
|b 23
700 1 _ |a Lev, Atar
|0 0000-0003-3416-1243
|b 24
700 1 _ |a Simon, Amos J
|0 0000-0003-0511-4122
|b 25
700 1 _ |a Montoya, Jorge
|0 0000-0002-6983-4770
|b 26
700 1 _ |a Barel, Ortal
|0 0000-0003-1168-9758
|b 27
700 1 _ |a Gómez-Rodríguez, Julio
|0 0009-0007-9708-419X
|b 28
700 1 _ |a Orrego, Julio C
|0 0000-0002-3809-9187
|b 29
700 1 _ |a L'Honneur, Anne-Sophie
|0 0000-0002-9228-0649
|b 30
700 1 _ |a Soudée, Camille
|0 0009-0002-1445-7223
|b 31
700 1 _ |a Rojas, Jessica
|0 0000-0002-5578-8160
|b 32
700 1 _ |a Velez, Alejandra C
|0 0000-0001-9157-8390
|b 33
700 1 _ |a Sereti, Irini
|0 0000-0002-0076-0224
|b 34
700 1 _ |a Terrier, Benjamin
|0 0000-0001-6612-7336
|b 35
700 1 _ |a Marin, Nancy
|0 0000-0002-2626-3349
|b 36
700 1 _ |a García, Luis F
|0 0000-0002-5343-0050
|b 37
700 1 _ |a Abel, Laurent
|0 0000-0001-7016-6493
|b 38
700 1 _ |a Boisson-Dupuis, Stéphanie
|0 0000-0002-7115-116X
|b 39
700 1 _ |a Reis, Joel
|0 0000-0002-8007-2420
|b 40
700 1 _ |a Marinho, Antonio
|b 41
700 1 _ |a Lisco, Andrea
|0 0000-0002-1475-356X
|b 42
700 1 _ |a Faria, Emilia
|0 0000-0002-9602-1599
|b 43
700 1 _ |a Goodnow, Christopher C
|0 0000-0001-5296-6155
|b 44
700 1 _ |a Vasconcelos, Julia
|0 0000-0002-7315-5703
|b 45
700 1 _ |a Béziat, Vivien
|0 0000-0002-4020-824X
|b 46
700 1 _ |a Ma, Cindy S
|0 0000-0001-5387-8413
|b 47
700 1 _ |a Somech, Raz
|0 0000-0001-6648-9425
|b 48
700 1 _ |a Casanova, Jean-Laurent
|0 0000-0002-7782-4169
|b 49
700 1 _ |a Bustamante, Jacinta
|0 0000-0002-3439-2482
|b 50
700 1 _ |a Franco, Jose Luis
|0 0000-0001-5664-6415
|b 51
700 1 _ |a Tangye, Stuart G
|0 0000-0002-5360-5180
|b 52
773 _ _ |a 10.1084/jem.20231044
|g Vol. 221, no. 5, p. e20231044
|0 PERI:(DE-600)1477240-1
|n 5
|p e20231044
|t Journal of experimental medicine
|v 221
|y 2024
|x 0022-1007
909 C O |p VDB
|o oai:inrepo02.dkfz.de:289207
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 14
|6 P:(DE-He78)6b4ebb9791b983b5620c0caaf3468e30
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 15
|6 P:(DE-He78)b48bfd64120195b64b5f11d32ce5ed5e
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF4-310
|0 G:(DE-HGF)POF4-314
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Immunologie und Krebs
|x 0
914 1 _ |y 2024
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b J EXP MED : 2022
|d 2023-08-24
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2023-08-24
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2023-08-24
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0320
|2 StatID
|b PubMed Central
|d 2023-08-24
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2023-08-24
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2023-08-24
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2023-08-24
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2023-08-24
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2023-08-24
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2023-08-24
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2023-08-24
915 _ _ |a IF >= 15
|0 StatID:(DE-HGF)9915
|2 StatID
|b J EXP MED : 2022
|d 2023-08-24
920 1 _ |0 I:(DE-He78)F020-20160331
|k F020
|l Infektionen und Krebs-Epidemiologie
|x 0
920 1 _ |0 I:(DE-He78)D320-20160331
|k D320
|l Infektionen und Krebs-Epidemiologie
|x 1
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)F020-20160331
980 _ _ |a I:(DE-He78)D320-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21